Literature DB >> 29229428

Not all HPV nucleic acid tests are equal: only those calibrated to detect high grade lesions matter for cervical screening: Response to 'Concordant testing results between various human papillomavirus assays in primary cervical cancer screening: systematic review' by de Thurah, Bonde, Uyen, Lam and Rebolj. Published 27 May, 2017.

L de Thurah1, J Bonde2, J U H Lam3, M Rebolj4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29229428     DOI： 10.1016/j.cmi.2017.12.001

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  2 in total

1.  Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework.

Authors:  Jesper Hansen Bonde; Helle Pedersen; Wim Quint; Lan Xu; Marc Arbyn; Ditte Møller Ejegod
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

2.  Validation of CINtec® PLUS Cytology Kit in the Diagnosis of Persistent HPV Infections - Cohort Study in the Portuguese Population.

Authors:  Ângela L Abreu; Regina A Silva; Sílvia Fernandes
Journal:  J Cytol       Date:  2021-05-10       Impact factor: 1.000
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.